Clinical Trial Site

Lisbon, Lisbon District 1649-035

2 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Running, not enrolling